Abstract:
OBJECTIVE:The objective of this study was to gain insights into the attitudes of men with lower urinary tract symptoms towards deprescribing alpha-blockers and to assess their willingness to participate in a planned discontinuation trial. METHODS:This was a cross-sectional questionnaire study. Men aged 30 years and older with lower urinary tract symptoms, who were first prescribed an alpha-blocker in 2015 or 2016, were selected from a population-based prescription database. We recorded lower urinary tract symptom severity (e.g., International Prostate Symptom Score and Overactive Bladder questionnaire) and patient characteristics (e.g., comorbidity and polypharmacy). The linguistically validated Dutch version of the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire was also used, to which we added ten specific questions on attitudes towards the deprescribing of alpha-blockers. Information about a future discontinuation trial on alpha-blockers was then provided and participants were asked to indicate if they would participate. We explored the explanatory factors for the willingness to participate by logistic regression analyses. RESULTS:Of the 1380 patients in the database, 421 were using an alpha-blocker, and 195 completed the questionnaire. Of these, 16 men were excluded because of indwelling catheter use or unknown indication. The mean age of the 179 participants was 69.4 (standard deviation 9.2) years. Most men were satisfied with their current therapy, but almost all (93%) were willing to stop the medicine at the request of a doctor. Therefore, most men (61%) were willing to participate in the proposed alpha-blocker discontinuation trial. Willingness to stop therapy was affected by patients' perceptions of the appropriateness of alpha-blocker therapy and concerns about stopping that therapy. CONCLUSIONS:Although men who use alpha-blockers are generally satisfied with their current therapy, most will participate in a discontinuation trial.
journal_name
Drugs Agingjournal_title
Drugs & agingauthors
Edelman M,Jellema P,Hak E,Denig P,Blanker MHdoi
10.1007/s40266-019-00712-6subject
Has Abstractpub_date
2019-12-01 00:00:00pages
1133-1139issue
12eissn
1170-229Xissn
1179-1969pii
10.1007/s40266-019-00712-6journal_volume
36pub_type
杂志文章相关文献
DRUGS & AGING文献大全abstract::Cutaneous adverse drug reactions comprise a significant proportion of all adverse drug reactions. They may mimic other dermatologic or systemic illnesses and may cause significant morbidity or mortality. Seven morphologic groups encompass the most commonly encountered cutaneous drug reaction syndromes: exanthematous (...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.1007/s40266-017-0483-5
更新日期:2017-09-01 00:00:00
abstract::Neuropathic pain (NeP) is a significant medical and socioeconomic burden with limited therapeutic options. Elderly patients exhibit a higher incidence of several NeP conditions and pose a particular challenge due to age-related pharmacokinetic and pharmacodynamic issues, comorbid conditions, and polypharmacy, as well ...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.1007/s40266-014-0218-9
更新日期:2014-12-01 00:00:00
abstract:BACKGROUND:Age-related changes in the concentration-effect relationship of (+)-O-desmethyl-tramadol [(+)-ODM], tramadol's active metabolite, are not documented in the elderly. OBJECTIVE:The objective of this study was to characterize, in elderly and young subjects, the (+)-ODM pharmacokinetic and pharmacodynamic relat...
journal_title:Drugs & aging
pub_type: 杂志文章,随机对照试验
doi:10.1007/s40266-019-00681-w
更新日期:2019-08-01 00:00:00
abstract::Erectile dysfunction (ED) is a common medical condition that affects the sexual life of millions of men worldwide. First-line oral therapy for ED includes the use of phosphodiesterase type 5 inhibitors (sildenafil, tadalafil and vardenafil) and sublingual apomorphine. Apomorphine is a dopamine D(1) and D(2) receptor a...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-200623040-00004
更新日期:2006-01-01 00:00:00
abstract::Periods of intense hormonal fluctuations have been associated with heightened prevalence and exacerbation of underlying psychiatric illness, particularly the occurrence of premenstrual dysphoria, puerperal depression and depressive symptoms during perimenopause. It has been speculated that sex steroids such as estroge...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-200320020-00001
更新日期:2003-01-01 00:00:00
abstract:BACKGROUND:Osteoporosis is a common cause of disability and death in elderly men and women. Until 2007, Australian Government-subsidized use of oral bisphosphonates, raloxifene and calcitriol (1alpha,25-dihydroxycholecalciferol) was limited to secondary prevention (requiring x-ray evidence of previous low-trauma fractu...
journal_title:Drugs & aging
pub_type: 杂志文章
doi:10.2165/11318400-000000000-00000
更新日期:2010-03-01 00:00:00
abstract::There is ample evidence for the involvement of aberrant protein phosphorylation reactions in aging and age-associated neurological disorders. Alzheimer's disease (AD) in particular. The exact nature of this involvement, however, is not yet elucidated. In the brain tissue of AD patients, there are numerous examples of ...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-199506020-00006
更新日期:1995-02-01 00:00:00
abstract::Gout in older patients tends to be sub-acute to chronic, often tophaceous, polyarticular, erosive, symmetrical, and causes persistent, recurrent and chronic arthritis. Clinically, it may closely mimic rheumatoid arthritis; thus, a correct diagnosis requires a high index of clinical suspicion and the identification of ...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-199404020-00005
更新日期:1994-02-01 00:00:00
abstract:BACKGROUND AND OBJECTIVE:Multiple drug use is common among old, frail nursing home residents who are, as a consequence, susceptible to adverse effects and drug interactions. This study uses the updated Beers criteria for potentially inappropriate drug (PID) use in older adults to determine the extent and nature of PIDs...
journal_title:Drugs & aging
pub_type: 杂志文章
doi:10.2165/00002512-200825080-00005
更新日期:2008-01-01 00:00:00
abstract::Primary hyperparathyroidism is a common metabolic bone disease and currently presents a significant management dilemma. Most of the patients have few relevant symptoms and surgical parathyroidectomy offers the prospect of cure with freedom from the risk of long-term complications or the need for a follow-up. However, ...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-200421150-00004
更新日期:2004-01-01 00:00:00
abstract:BACKGROUND:Falls are a primary cause of injury and disability in the nursing home environment and can be costly to treat. We propose a taxonomy of nursing home falls that accounts for both the severity of fall consequences and the duration of the treatment episode. No other systematic approach of this kind has been pre...
journal_title:Drugs & aging
pub_type: 杂志文章
doi:10.2165/00002512-200623030-00007
更新日期:2006-01-01 00:00:00
abstract::Behavioural disturbances, also termed neuropsychiatric symptoms, are a frequent clinical feature of dementia in Alzheimer's disease (AD). Many AD patients receive treatment with cholinesterase inhibitors (ChEIs). This review examines the evidence for behavioural effects of the four ChEIs that have been approved for th...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-200623120-00003
更新日期:2006-01-01 00:00:00
abstract:BACKGROUND:Frailty is a clinical phenotype that is associated with adverse health outcomes. Since frail patients may be more prone for adverse drug events and about 15-20 % of commonly prescribed drugs are metabolized by CYP2D6, we hypothesized that CYP2D6 metabolism is decreased in frail patients compared with healthy...
journal_title:Drugs & aging
pub_type: 杂志文章
doi:10.1007/s40266-015-0319-0
更新日期:2015-12-01 00:00:00
abstract:PURPOSE:Older adults receiving cytotoxic agents may be more susceptible to hematologic toxicities because of progressive reduction in organ functions and multiple co-morbidities. Because older adults are under-represented in clinical trials, this retrospective study aims to evaluate hematologic toxicity of gemcitabine-...
journal_title:Drugs & aging
pub_type: 杂志文章,多中心研究
doi:10.1007/s40266-014-0207-z
更新日期:2014-10-01 00:00:00
abstract:BACKGROUND:Evidence regarding differences in outcomes between angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) among older nursing home (NH) residents after acute myocardial infarction (AMI) is limited. OBJECTIVES:The purpose of our study was to estimate the post-AMI effects...
journal_title:Drugs & aging
pub_type: 杂志文章
doi:10.1007/s40266-020-00791-w
更新日期:2020-10-01 00:00:00
abstract:INTRODUCTION:Congestive heart failure (CHF), which typically affects older people, is characterized by high short- and mid-term mortality rates. However, despite accumulating evidence showing that administration of β-blockers (β-adrenoceptor antagonists) can improve the clinical status of CHF patients, use of these age...
journal_title:Drugs & aging
pub_type: 杂志文章,随机对照试验
doi:10.2165/11538210-000000000-00000
更新日期:2010-10-01 00:00:00
abstract:BACKGROUND:Optimal use of digoxin in the elderly population requires information about the drug's pharmacokinetics and the influence of various factors on the drug's disposition. However, because of sampling restrictions, it is often difficult to perform traditional pharmacokinetic studies in elderly patients. OBJECTI...
journal_title:Drugs & aging
pub_type: 杂志文章
doi:10.2165/11594230-000000000-00000
更新日期:2011-10-01 00:00:00
abstract::Despite a sharp decline in the incidence of gastric cancer during the second half of the 20th century, this malignancy remains the second leading cause of cancer mortality in the world. The incidence and mortality rate of gastric cancer increase with age; at present, the median ages at diagnosis are 67 years for men a...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/11315740-000000000-00000
更新日期:2009-01-01 00:00:00
abstract::The focus of this review is hormone replacement therapy (HRT) with continuous oral 17 beta-estradiol (herein referred to as estradiol) 2 mg/day plus sequential oral dydrogesterone 10 or 20 mg/day for 14 days of each 28-day cycle. According to data from nonblind trials, this regimen relieves climacteric symptoms, prese...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-199711040-00006
更新日期:1997-10-01 00:00:00
abstract::Urothelial carcinoma, or bladder cancer, is a malignancy that most commonly affects older patients. The median age at diagnosis is 73 years, and care of these patients requires consideration not just of the disease-related factors such as stage and histology, but also of patient-related factors. Many of these patients...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.1007/s40266-018-0540-8
更新日期:2018-05-01 00:00:00
abstract::The incidence of pneumonia is highest among the aged compared with other adult populations, and causes significant morbidity and mortality among this group. Most episodes of pneumonia are caused by aspiration of oropharyngeal flora into the lungs and failure of lung defence mechanisms to eliminate the aspirated bacter...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-199404010-00003
更新日期:1994-01-01 00:00:00
abstract::NSAIDs are a widely used class of analgesic and anti-inflammatory drugs that act by inhibiting the cyclo-oxygenase (COX) enzyme. However, because of their nonspecificity of action, use of these agents as long-term therapy for chronic pain in diseases such as rheumatoid arthritis (RA) and osteoarthritis (OA) is often d...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-200724060-00001
更新日期:2007-01-01 00:00:00
abstract::Lisinopril, the lysine analogue of enalaprilat, is a long-acting angiotensin converting enzyme (ACE) inhibitor which is administered once daily by mouth. The efficacy of lisinopril in reducing blood pressure is well established in younger populations, and many trials now show it to be effective in lowering blood press...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-199710020-00006
更新日期:1997-02-01 00:00:00
abstract::The numbers of patients with dementia and patients with epilepsy are increasing in the global population. In fact, these two conditions are related, and it is estimated that at least 5-10% of seizures or epilepsy in older individuals (aged > 60 years) are caused by a neurodegenerative dementia. In the vast majority, o...
journal_title:Drugs & aging
pub_type: 杂志文章
doi:10.1007/s40266-020-00826-2
更新日期:2020-12-14 00:00:00
abstract:BACKGROUND:Inappropriate medications are often used in older adults despite their unfavourable risk-to-benefit profile. Although many of the medications in the American Geriatrics Society (AGS) Beers list are potentially inappropriate because of their anticholinergic properties, little is known regarding the nature and...
journal_title:Drugs & aging
pub_type: 杂志文章
doi:10.1007/s40266-015-0257-x
更新日期:2015-05-01 00:00:00
abstract:BACKGROUND:Use of combination pharmacotherapy, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II type 1 receptor antagonists (angiotensin receptor blockers) and β-adrenoceptor antagonists (β-blockers) in the management of heart failure (HF) can reduce mortality, prevent functional decline and red...
journal_title:Drugs & aging
pub_type: 杂志文章
doi:10.2165/11592420-000000000-00000
更新日期:2011-07-01 00:00:00
abstract::Intracavernous alprostadil (synthetic prostaglandin E1) is a vasodilating agent which acts by relaxing the smooth muscles of the corpus cavernosum and by increasing the diameter of cavernous arteries; this leads to erection. Following intracavernous administration, alprostadil is either locally metabolised or rapidly ...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-199608010-00009
更新日期:1996-01-01 00:00:00
abstract:BACKGROUND/OBJECTIVES:Patients with congestive heart failure (CHF) have a high prevalence of cognitive impairment and the association is multifactorial. In general, the burden of anticholinergic drugs has consistently been shown to be a risk factor for cognitive impairment in the elderly. The aim of this study was to a...
journal_title:Drugs & aging
pub_type: 杂志文章
doi:10.1007/s40266-014-0204-2
更新日期:2014-10-01 00:00:00
abstract::The atypical antipsychotics are a new class of agents with great promise for use in the elderly because of their reduced propensity to cause acute extrapyramidal adverse effects. Treatment of older patients with these agents, however, needs to take into consideration age-related changes in pharmacokinetics and the ris...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.2165/00002512-199812020-00004
更新日期:1998-02-01 00:00:00
abstract::Psoriatic arthritis (PsA) can start in subjects aged over 60 years, defined as late-onset PsA. In late-onset PsA, the weight of family history and genetic background appears less significant when compared with younger onset PsA, whereas obesity and smoking have been suggested as potential risk factors. In patients wit...
journal_title:Drugs & aging
pub_type: 杂志文章,评审
doi:10.1007/s40266-019-00688-3
更新日期:2019-10-01 00:00:00